NLS Pharmaceutics AG (NLSP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NLS Pharmaceutics AG

    NASDAQ: NLSP · Real-Time Price · USD
    2.00
    -0.12 (-5.66%)
    At close: Oct 03, 2025, 3:59 PM
    1.98
    -0.75%
    After-hours: Oct 03, 2025, 07:41 PM EDT

    NLS Pharmaceutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Net Income
    		 -1.98M -2.04M -7.62M -15.47M -16.5M -15.98M -11.95M -6.23M
    Depreciation & Amortization
    		 3.32K 5.71K 5.71K 11.41K 11.41K 10.73K 10.05K 72.19M
    Stock-Based Compensation
    		 67.07K 104.39 164.91 83.25 22.73 n/a n/a n/a
    Other Working Capital
    		 195.74K 915.25K -8.54K 320.27K 990.55K 1.1M -875.26K -1.62M
    Other Non-Cash Items
    		 -2.5M -4.27M -5.05M 465.92K 364.64K -1.94M 2.48M 2.42M
    Deferred Income Tax
    		 n/a n/a 728.28K 568.27K -160.01K n/a n/a n/a
    Change in Working Capital
    		 146.49K 2.39M 2.25M 911.44K 1.63M 3.08M -3.17M -3.87M
    Operating Cash Flow
    		 -4.27M -3.92M -9.68M -13.51M -13.88M -12.87M -14.94M -9.93M
    Capital Expenditures
    		 -3.92K 2.39M 2.39M n/a n/a -6.8K -39.56K -32.76K
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 -3.92K n/a n/a -7.6M -3.52M 4.07M -39.56K 99.52K
    Debt Repayment
    		 n/a -194.72K n/a n/a n/a n/a -1.43K 646.91K
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 1.63M 1.63M 13.81M 13.81M 3.55M 20.34M 16.21M
    Financial Cash Flow
    		 5.04M 2.82M 1.63M 13.81M 17.4M 7.14M 20.34M 16.85M
    Net Cash Flow
    		 767.72K -1.1M -8.05M 297.26K 3.52M -5.74M 5.34M 6.95M
    Free Cash Flow
    		 -4.27M -1.53M -7.3M -13.51M -13.88M -12.87M -14.98M -9.96M

    Add to Watchlist